RKIP does not contribute to MAP kinase pathway silencing in the Merkel Cell Carcinoma cell line UISO

<p>Abstract</p> <p>Background</p> <p>The Raf kinase inhibitor protein (RKIP) has been shown to block MAP kinase pathway as well as NFκB signalling. By means of immunohistochemistry, we previously demonstrated that the MAP kinase pathway is virtually inactive in Merkel c...

Full description

Bibliographic Details
Main Authors: Houben Roland, Ortmann Sonja, Becker Juergen C
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2007-10-01
Series:Journal of Carcinogenesis
Online Access:http://www.carcinogenesis.com/content/6/1/16